中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2011年
20期
1422-1426
,共5页
彭阳红%张锦明%周乃康%金小海%陈大明%高慧波
彭暘紅%張錦明%週迺康%金小海%陳大明%高慧波
팽양홍%장금명%주내강%금소해%진대명%고혜파
肺肿瘤%放射疗法%动物实验%碘放射性同位素%钯放射性同位素
肺腫瘤%放射療法%動物實驗%碘放射性同位素%鈀放射性同位素
폐종류%방사요법%동물실험%전방사성동위소%파방사성동위소
Lung neoplasms%Radiotherapy%Animal experimentation%Iodine radioisotopes%Palladium radioisotopes
目的 制备125I-103Pd复合型放射性粒子,并探讨其对肺癌的杀伤效果.方法 利用化学镀层方法制备125I-103Pd放射性粒子.体外培养肺腺癌GLC-82细胞及大细胞癌H460细胞,将125I-103Pd.125I、103Pd及空白粒子置于细胞培养皿中照射48 h,观察粒子对肿瘤细胞的杀伤效应.40只BALB/c-nu小鼠随机平分为2组,分别构建GLC-82及H460的移植瘤模型,每种模型荷瘤鼠随机分成_4组,每组5只.将125I-103pd、125I、103Pd及空白粒子分别植入裸鼠的移植瘤内,每5天定期测量移植瘤大小及裸鼠体重变化,观察61 d.结果 成功制备125I-103Pd粒子.粒子照射细胞48 h后,125I、103Pd及125I-103Pd粒子周围约1个粒子直径范围内的GLC-82细胞明显肿胀、变形,生长抑制;125I粒子周围H460细胞牛长无明显改变,而103Pd及125I-103Pd粒子周围约1个粒子直径内H460细胞生长稀少.体内实验小鼠无死亡,H460移植瘤较GLC-82移植瘤生长快,放射性粒子对两种移植瘤均有抑制,抑瘤效果:125I-103pd粒子>103Pd粒子≈125I粒子>空白粒子;同种放射性粒子对GLC-82移植瘤的抑制效果较H460移植瘤好.结论 125I-103Pd复合型放射性粒子制备工艺可行,抑瘤效果较好,具有较好的应用前景.
目的 製備125I-103Pd複閤型放射性粒子,併探討其對肺癌的殺傷效果.方法 利用化學鍍層方法製備125I-103Pd放射性粒子.體外培養肺腺癌GLC-82細胞及大細胞癌H460細胞,將125I-103Pd.125I、103Pd及空白粒子置于細胞培養皿中照射48 h,觀察粒子對腫瘤細胞的殺傷效應.40隻BALB/c-nu小鼠隨機平分為2組,分彆構建GLC-82及H460的移植瘤模型,每種模型荷瘤鼠隨機分成_4組,每組5隻.將125I-103pd、125I、103Pd及空白粒子分彆植入裸鼠的移植瘤內,每5天定期測量移植瘤大小及裸鼠體重變化,觀察61 d.結果 成功製備125I-103Pd粒子.粒子照射細胞48 h後,125I、103Pd及125I-103Pd粒子週圍約1箇粒子直徑範圍內的GLC-82細胞明顯腫脹、變形,生長抑製;125I粒子週圍H460細胞牛長無明顯改變,而103Pd及125I-103Pd粒子週圍約1箇粒子直徑內H460細胞生長稀少.體內實驗小鼠無死亡,H460移植瘤較GLC-82移植瘤生長快,放射性粒子對兩種移植瘤均有抑製,抑瘤效果:125I-103pd粒子>103Pd粒子≈125I粒子>空白粒子;同種放射性粒子對GLC-82移植瘤的抑製效果較H460移植瘤好.結論 125I-103Pd複閤型放射性粒子製備工藝可行,抑瘤效果較好,具有較好的應用前景.
목적 제비125I-103Pd복합형방사성입자,병탐토기대폐암적살상효과.방법 이용화학도층방법제비125I-103Pd방사성입자.체외배양폐선암GLC-82세포급대세포암H460세포,장125I-103Pd.125I、103Pd급공백입자치우세포배양명중조사48 h,관찰입자대종류세포적살상효응.40지BALB/c-nu소서수궤평분위2조,분별구건GLC-82급H460적이식류모형,매충모형하류서수궤분성_4조,매조5지.장125I-103pd、125I、103Pd급공백입자분별식입라서적이식류내,매5천정기측량이식류대소급라서체중변화,관찰61 d.결과 성공제비125I-103Pd입자.입자조사세포48 h후,125I、103Pd급125I-103Pd입자주위약1개입자직경범위내적GLC-82세포명현종창、변형,생장억제;125I입자주위H460세포우장무명현개변,이103Pd급125I-103Pd입자주위약1개입자직경내H460세포생장희소.체내실험소서무사망,H460이식류교GLC-82이식류생장쾌,방사성입자대량충이식류균유억제,억류효과:125I-103pd입자>103Pd입자≈125I입자>공백입자;동충방사성입자대GLC-82이식류적억제효과교H460이식류호.결론 125I-103Pd복합형방사성입자제비공예가행,억류효과교호,구유교호적응용전경.
Objective To prepared 125I-103Pd hybrid radioactive seeds and to explore their therapeutic effect on pulmonary carcinomas.nethods The 125I-103Pd hybrid radioactive seeds were prepared by a chemical method of step-by-step coat plating.Pulmonary adenocarcinoma of GLC-82 cells and pulmonary large cell carcinoma of H460 cells were cultured in vitro and then were exposed directly to125I,103pd and125I103pd seeds for 48 hours to observe the killing effects of radiation.GLC-82 and H460 tumor models were established and 20 mice chosen randomly for each model.For each tumor model.there were 4 groups(n=5 each).Then 125I-103pd,125I,103Pd and nonradioactive seeds were implanted into the tumors.Tumor sizes and weights of mice were measured and recorded every 5 days for a 2-month observation.Resuits The125I-103Pd hybrid radioactive seeds were prepared successfully.After a 48-hour radiation from radioactive seeds, the GLC-82 cells within one particulate around 125I,103Pd or1 25I_103Pd seeds were inhibited so as to become swollen and transfiguring.The H460 cells around125I seeds showed no obvious abnormality while those within one Darticalate around 103Pd or125I-103pd seeds were much fewer. No mouse died during the observation period.The radioactive seeds could inhibit the tumors.The radiotherapeutie effects were similar in two tumor modes:125I_103Pd seeds>103Pd seeds≈125I seeds>non-radioactive seeds.H460 tumors grew much faster than GLC-82 tumors.Meanwhile the seeds with the same nuclide were much more effective for GLC-82 tumors than for H460 tumors.Conclusion TheI_l03pd hybrid radioactive seeds are clinically applieable due to their effective inhibitions of tumor growth.